National Academy of Medicine

Expanding the Role of N-of-1 Trials in the Precision Medicine Era: Action Priorities and Practical Considerations

  Heterogeneous responses to the same therapy among individual patients are commonp
Read More

A Proposed Approach for Implementing Genomics-Based Screening Programs for Healthy Adults

The central idea of early disease detection and treatment is essentially simple. However, the path to its succe
Read More

Moving Data Sharing Forward: The Launch of the Vivli Platform

Introduction On January 14, 2015, the Institute of Medicine (IOM) released a consensus study report titled Sharing Clinical Trial Data: Maxi
Read More

Cancer Prevention and Control: Then and Now

Controlling or reducing the risk for cancer was a principal goal of the National Cancer Act, signed by President Nixon in 1971. Long before the human genome w
Read More

A Vision for a Person-Centered Health Information System

  Introduction The person-centered health information system (PCHIS) of the future leverages information technology enhanced by artificial
Read More

The Evolving Case for Public-Private Partnerships to Achieve the Global Goals

  Upon arriving in Kenya in 1987, I was a well-trained parasitologist who knew nothing about development, economics, p
Read More

Clinical Perspectives on Obesity Treatment: Challenges, Gaps, and Promising Opportunities

Introduction In April 2017, the Roundtable on Obesity Solutions of the National Academies of Sciences, Engineering
Read More

It’s Time to Harmonize Clinical Trial Site Standards

Climbing costs and lengthy time frames of clinical trials are significant bottlenecks in medical product development. Despite the fact that scientifi
Read More